Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 1,089 Shares of Stock
Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 1,089 shares of the stock in a transaction on Friday, January 12th. The shares were sold at an average price of $108.19, for a total value of $117,818.91. Following the sale, the executive vice president now owns 27,751 shares of the company’s stock, valued at approximately $3,002,380.69. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Shares of Varian Medical Systems, Inc. (VAR) opened at $109.32 on Thursday. The stock has a market capitalization of $10,020.00, a price-to-earnings ratio of 39.61, a PEG ratio of 3.30 and a beta of 0.68. Varian Medical Systems, Inc. has a 1-year low of $76.94 and a 1-year high of $114.09.
Varian Medical Systems (NYSE:VAR) last released its earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.19 by ($0.10). The business had revenue of $739.00 million during the quarter, compared to analysts’ expectations of $741.69 million. Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. Varian Medical Systems’s revenue for the quarter was down 1.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.03 EPS. sell-side analysts forecast that Varian Medical Systems, Inc. will post 4.11 earnings per share for the current fiscal year.
A number of equities research analysts have recently commented on VAR shares. Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, October 29th. Citigroup increased their target price on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a report on Monday, October 30th. Royal Bank of Canada set a $105.00 target price on Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. Finally, Evercore ISI assumed coverage on Varian Medical Systems in a report on Wednesday, January 3rd. They issued an “underperform” rating and a $100.00 target price for the company. Three analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company’s stock. Varian Medical Systems has a consensus rating of “Hold” and a consensus price target of $100.44.
ILLEGAL ACTIVITY NOTICE: This piece was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.watchlistnews.com/insider-selling-varian-medical-systems-inc-var-evp-sells-1089-shares-of-stock/1811851.html.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.